Deutsche Märkte schließen in 2 Stunden 23 Minuten

Eledon Pharmaceuticals, Inc. (2TK.F)

Frankfurt - Frankfurt Verzögerter Preis. Währung in EUR
Zur Watchlist hinzufügen
2,2800-0,1200 (-5,00%)
Ab 08:20AM CEST. Markt geöffnet.

Insider-Transaktionen

Währung in EUR
Insider-Käufe (letzte 6 Monate)AktienTrans
Käufe00
VerkaufN/A0
Gekaufte Nettoaktien (verkauft)00
Insideraktien mit Beteiligung (gesamt)1,35MN/A
% Gekaufte Nettoaktien (verkauft)N/AN/A
Institutionelle Käufe (netto) der letzten QuartaleAktien
Gekaufte Nettoaktien (verkauft)N/A
% Schwankung in institutioneller AktienbeteiligungN/A

Gemeldete Insider-Transaktionen – Letzte zwei Jahre

InsiderTransaktionTypWertDatumAktien

BVF PARTNERS L P
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 2.40 per share.Indirekt4.627.04909. Mai 20241.927.937

BVF PARTNERS L P
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 2.68 per share.Indirekt5.303.53805. Mai 20231.978.932

PERRIN STEVEN
President

Purchase at price 2.60 per share.Direkt2.59723. Nov. 20221.000

GROS DAVID-ALEXANDRE C
Chief Executive Officer

Purchase at price 4.48 per share.Direkt8.96020. Dez. 20212.000

GROS DAVID-ALEXANDRE C
Chief Executive Officer

Purchase at price 6.21 per share.Direkt24.84017. Aug. 20214.000

LITTLE PAUL SEAN
Chief Financial Officer

Purchase at price 8.87 per share.Direkt88.70011. Juni 202110.000

GROS DAVID-ALEXANDRE C
Chief Executive Officer

Purchase at price 8.01 per share.Direkt24.03009. Juni 20213.000

BVF PARTNERS L.P.
Beneficial Owner of more than 10% of a Class of Security

Indirekt22. Dez. 20201.289.628

ORBIMED ISRAEL GP LTD.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 21.60 per share.Indirekt2.229.12002. Dez. 2020103.200

LOGOS GLOBAL MANAGEMENT LP
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 24.03 - 26.48 per share.Indirekt2.341.71430. Okt. 202092.040

LOGOS GLOBAL MANAGEMENT LP
Beneficial Owner of more than 10% of a Class of Security

Sale at price 26.64 - 27.02 per share.Indirekt345.55930. Okt. 202012.969

TURKEL CATHERINE C
President

Sale at price 1.91 - 1.96 per share.Direkt18.61221. Mai 20199.537

FLESHER GREGORY J.
Chief Executive Officer

Sale at price 1.91 - 1.96 per share.Direkt28.56621. Mai 201914.638

KUWAHARA JON S
Officer

Sale at price 1.91 - 1.96 per share.Direkt10.29621. Mai 20195.276

ORBIMED ISRAEL GP LTD.
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 3.10 per share.Indirekt2.003.23202. Mai 2019646.204

CHIMOVITS EREZ
Director

Purchase at price 3.10 per share.Indirekt2.003.23202. Mai 2019646.204

LIFESCI INDEX PARTNERS, LLC
Beneficial Owner of more than 10% of a Class of Security

Sale at price 2.70 per share.Indirekt54030. Apr. 2019200

TURKEL CATHERINE C
President

Stock Award(Grant) at price 0.00 per share.Direkt014. März 201920.000

FLESHER GREGORY J.
Chief Executive Officer

Stock Award(Grant) at price 0.00 per share.Direkt014. März 201925.000

TURKEL CATHERINE C
President

Purchase at price 4.56 - 5.02 per share.Direkt161.14712. Sept. 201833.680

TURKEL CATHERINE C
President

Purchase at price 3.97 per share.Indirekt3.19305. Sept. 2018805

TURKEL CATHERINE C
President

Stock Award(Grant) at price 0.00 per share.Direkt013. März 201820.000

FLESHER GREGORY J.
Chief Executive Officer

Stock Award(Grant) at price 0.00 per share.Direkt013. März 201830.700

KUWAHARA JON S
Officer

Stock Award(Grant) at price 0.00 per share.Direkt013. März 201811.250

OCAMPO CHRISTINE G
Chief Financial Officer

Purchase at price 0.61 per share.Direkt54.91910. Mai 201790.090

TURKEL CATHERINE C
Officer

Purchase at price 0.61 per share.Direkt60.95910. Mai 201799.999

FLESHER GREGORY J.
Chief Executive Officer

Purchase at price 0.61 per share.Direkt323.47310. Mai 2017530.631

ORBIMED ISRAEL GP LTD.
Director and Beneficial Owner of more than 10% of a Class of Security

Stock Award(Grant) at price 0.00 per share.Indirekt009. Mai 20172.537.110

BUCKLEY STEPHEN JR
Director

Purchase at price 5.74 per share.Direkt45.92015. März 20168.000

MORRISON JODIE POPE
Chief Executive Officer

Conversion of Exercise of derivative security at price 0.63 - 1.37 per share.Direkt32.44908. Jan. 201628.015

BUCKLEY STEPHEN JR
Director

Purchase at price 11.25 per share.Direkt33.75011. Nov. 20153.000

MCBRIDE JOHN S
Chief Operating Officer

Sale at price 14.01 per share.Direkt189.13521. Sept. 201513.500

MCBRIDE JOHN S
Chief Operating Officer

Conversion of Exercise of derivative security at price 4.19 per share.Direkt56.56521. Sept. 201513.500

KALOWSKI LEE
Chief Financial Officer

Sale at price 13.13 per share.Direkt61.29108. Sept. 20154.668

KALOWSKI LEE
Chief Financial Officer

Sale at price 12.96 per share.Direkt27.96802. Sept. 20152.158

MORRISON JODIE POPE
Chief Executive Officer

Sale at price 13.70 per share.Direkt172.12729. Juli 201512.564

MORRISON JODIE POPE
Chief Executive Officer

Conversion of Exercise of derivative security at price 0.63 - 1.58 per share.Direkt28.37129. Juli 201522.564

MORRISON JODIE POPE
Chief Executive Officer

Conversion of Exercise of derivative security at price 0.63 - 2.31 per share.Direkt10.62422. Juli 201510.000

NOVARTIS BIOVENTURES, LTD.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 14.26 per share.Indirekt50.84415. Juli 20153.566

NOVARTIS BIOVENTURES, LTD.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 14.20 - 14.41 per share.Indirekt694.19414. Juli 201548.472

MORRISON JODIE POPE
Chief Executive Officer

Sale at price 13.70 - 13.83 per share.Direkt220.24029. Juni 201516.000

MORRISON JODIE POPE
Chief Executive Officer

Conversion of Exercise of derivative security at price 1.58 per share.Direkt25.28029. Juni 201516.000

MCBRIDE JOHN S
Chief Operating Officer

Sale at price 14.00 - 14.20 per share.Direkt126.10024. Juni 20159.000

MCBRIDE JOHN S
Chief Operating Officer

Conversion of Exercise of derivative security at price 4.19 per share.Direkt37.71024. Juni 20159.000

NOVARTIS BIOVENTURES LTD.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 14.27 per share.Direkt15.98216. Juni 20151.120

NOVARTIS BIOVENTURES LTD.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 14.20 per share.Direkt293.88315. Juni 201520.696

NOVARTIS BIOVENTURES LTD.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 14.20 per share.Direkt395.82511. Juni 201527.875

KALOWSKI LEE
Chief Financial Officer

Sale at price 13.00 per share.Direkt59.37116. Apr. 20154.567

KALOWSKI LEE
Chief Financial Officer

Sale at price 11.45 per share.Direkt25.85402. Apr. 20152.258

NOVARTIS BIOVENTURES LTD.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 14.50 per share.Indirekt712.54419. März 201549.141

BARBERICH TIMOTHY J
Director

Conversion of Exercise of derivative security at price 0.00 per share.Direkt022. Sept. 2014121.077

SATTER MANAGEMENT CO., L.P.
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 15.00 per share.Indirekt2.250.00022. Sept. 2014150.000

SATTER MANAGEMENT CO., L.P.
Beneficial Owner of more than 10% of a Class of Security

Indirekt22. Sept. 20141.621.688

HARRISON SETH LORING
Director and Beneficial Owner of more than 10% of a Class of Security

Purchase at price 15.00 per share.Indirekt5.437.50022. Sept. 2014362.500

HARRISON SETH LORING
Director and Beneficial Owner of more than 10% of a Class of Security

Conversion of Exercise of derivative security at price 0.00 per share.Indirekt022. Sept. 20147.549.570

APPLE TREE PARTNERS II L P
Beneficial Owner of more than 10% of a Class of Security

Conversion of Exercise of derivative security at price 0.00 per share.Direkt022. Sept. 20144.218.632

APPLE TREE PARTNERS II ANNEX L P
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 15.00 per share.Direkt3.562.50022. Sept. 2014237.500

APPLE TREE PARTNERS II ANNEX L P
Beneficial Owner of more than 10% of a Class of Security

Conversion of Exercise of derivative security at price 0.00 per share.Direkt022. Sept. 20143.330.938

KALOWSKI LEE
Chief Financial Officer

Stock Award(Grant) at price 0.00 per share.Direkt017. Sept. 201454.604